JournalsHub
.online
Find My Journal
ÉB

Éric Baudin

Institut Gustave Roussy FR

ORCID iD 0000-0002-2198-3582
679
Publications
69,984
Citations
116
H-Index
318
i10-Index
6.65
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

647 total

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial PDF

Samuel A. Wells, Bruce G. Robinson, Robert F. Gagel, Henning Dralle, James A. Fagin et al. - Journal of Clinical Oncology, 2011
Cited by 1,532 OpenAlex

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

Marianne Pavel, John D. Hainsworth, Éric Baudin, Marc Peeters, Dieter Hörsch et al. - The Lancet, 2011
Cited by 1,047 OpenAlex

Research Topics

Neuroendocrine Tumor Research Advances (257) Adrenal and Paraganglionic Tumors (153) Neuroblastoma Research and Treatments (151) Thyroid Cancer Diagnosis and Treatment (146) Lung Cancer Research Studies (145)

Affiliations

Université Claude Bernard Lyon 1
FR 2014 - 2010
Université Paris-Sud
FR 2020 - 2010
Université de Tours
FR 2020 - 2020
United States Nuclear Regulatory Commission
US 2012 - 2012
Cedars-Sinai Medical Center
US 2012 - 2012

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now